中/EN Contact/Message
  • Home
  • central pharmacy
  • Policies
  • Medical Institution
  • Franchise
  • Innovate
  • Recruit
  • News
  • Home
  • central pharmacy
  • Policies
  • Medical Institution
  • Franchise
  • Innovate
  • Recruit
  • News
  • 中/EN
  • Contact/Message
    • Innovate
    Your current position：
    Elfabrio
    Elfabrio
    departments：内科
    drug：注射液
    Active：pegunigalsidase alfa-iwxj
    indication：治疗确诊的法布里病
    Licensor：Chiesi Farmaceutici S.p.A.
    Approved Country/Region：FDA
    Approval time：2023-05-09